Black Diamond Therapeutics (BDTX) Other Gross PP&E Adjustments (2018 - 2021)
Historic Other Gross PP&E Adjustments for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q3 2021 value amounting to -$25.2 million.
- Black Diamond Therapeutics' Other Gross PP&E Adjustments fell 21200.99% to -$25.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$25.2 million, marking a year-over-year decrease of 21200.99%. This contributed to the annual value of -$9.3 million for FY2020, which is 1170875.0% down from last year.
- Black Diamond Therapeutics' Other Gross PP&E Adjustments amounted to -$25.2 million in Q3 2021, which was down 21200.99% from -$10.5 million recorded in Q2 2021.
- In the past 5 years, Black Diamond Therapeutics' Other Gross PP&E Adjustments ranged from a high of $234000.0 in Q4 2018 and a low of -$25.2 million during Q3 2021
- Moreover, its 4-year median value for Other Gross PP&E Adjustments was -$8.1 million (2020), whereas its average is -$7.3 million.
- As far as peak fluctuations go, Black Diamond Therapeutics' Other Gross PP&E Adjustments crashed by 6581.2% in 2019, and later crashed by 1291851.85% in 2021.
- Black Diamond Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $234000.0 in 2018, then tumbled by 65.81% to $80000.0 in 2019, then plummeted by 11708.75% to -$9.3 million in 2020, then plummeted by 171.63% to -$25.2 million in 2021.
- Its Other Gross PP&E Adjustments stands at -$25.2 million for Q3 2021, versus -$10.5 million for Q2 2021 and -$12.8 million for Q1 2021.